[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

In-Vitro Colorectal Cancer Screening Tests Market in UK - Industry Outlook and Forecast 2020-2026

April 2020 | 92 pages | ID: ID3BD2B367F8EN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

This report contains market size and forecasts of In-Vitro Colorectal Cancer Screening Tests in UK, including the following market information:
UK In-Vitro Colorectal Cancer Screening Tests Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in UK In-Vitro Colorectal Cancer Screening Tests Market 2019 (%)
The global In-Vitro Colorectal Cancer Screening Tests market was valued at 964.8 million in 2019 and is projected to reach US$ 1185 million by 2026, at a CAGR of 5.3% during the forecast period. While the In-Vitro Colorectal Cancer Screening Tests market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on In-Vitro Colorectal Cancer Screening Tests businesses, with lots of challenges and uncertainty faced by many players of In-Vitro Colorectal Cancer Screening Tests in UK. This report also analyses and evaluates the COVID-19 impact on In-Vitro Colorectal Cancer Screening Tests market size in 2020 and the next few years in UK

Total Market by Segment:

UK In-Vitro Colorectal Cancer Screening Tests Market, By Type, 2015-2020, 2021-2026 ($ millions)
UK In-Vitro Colorectal Cancer Screening Tests Market Segment Percentages, By Type, 2019 (%)
  • Biomarker Tests
  • Fecal Occult Blood Tests
  • CRC DNA Screening Tests
UK In-Vitro Colorectal Cancer Screening Tests Market, By Application, 2015-2020, 2021-2026 ($ millions)
UK In-Vitro Colorectal Cancer Screening Tests Market Segment Percentages, By Application, 2019 (%)
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Competitor Analysis

The report also provides analysis of leading market participants including:
Total In-Vitro Colorectal Cancer Screening Tests Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)
Total In-Vitro Colorectal Cancer Screening Tests Market Competitors Revenues Share in UK, by Players 2019 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Alere(Abbott)
  • Beckman Coulter
  • Siemens Healthcare
  • Eiken Chemical
  • Hitachi Chemical (Kyowa Medex)
  • Clinical Genomics Pty Ltd (Quest Diagnostics)
  • Sysmex
  • QIAGEN
  • R-Biopharm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 In-Vitro Colorectal Cancer Screening Tests Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 COVID-19 Impact: UK In-Vitro Colorectal Cancer Screening Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 UK IN-VITRO COLORECTAL CANCER SCREENING TESTS OVERALL MARKET SIZE

2.1 UK In-Vitro Colorectal Cancer Screening Tests Market Size: 2020 VS 2026
2.2 UK In-Vitro Colorectal Cancer Screening Tests Revenue, Prospects & Forecasts: 2015-2026

3 COMPANY LANDSCAPE

3.1 Top In-Vitro Colorectal Cancer Screening Tests Players in UK (including Foreign and Local Companies)
3.2 Top UK In-Vitro Colorectal Cancer Screening Tests Companies Ranked by Revenue
3.3 UK In-Vitro Colorectal Cancer Screening Tests Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 In-Vitro Colorectal Cancer Screening Tests Companies in UK, by Revenue in 2019
3.5 UK Manufacturers In-Vitro Colorectal Cancer Screening Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Players in UK
  3.6.1 List of UK Tier 1 In-Vitro Colorectal Cancer Screening Tests Companies
  3.6.2 List of UK Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - UK In-Vitro Colorectal Cancer Screening Tests Market Size Markets, 2020 & 2026
  4.1.2 Biomarker Tests
  4.1.3 Fecal Occult Blood Tests
  4.1.4 CRC DNA Screening Tests
4.2 By Type - UK In-Vitro Colorectal Cancer Screening Tests Revenue & Forecasts
  4.2.1 By Type - UK In-Vitro Colorectal Cancer Screening Tests Revenue, 2015-2020
  4.2.2 By Type - UK In-Vitro Colorectal Cancer Screening Tests Revenue, 2021-2026
  4.2.3 By Type - UK In-Vitro Colorectal Cancer Screening Tests Revenue Market Share, 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - UK In-Vitro Colorectal Cancer Screening Tests Market Size, 2020 & 2026
  5.1.2 Hospital and Clinics
  5.1.3 Ambulatory
  5.1.4 Home Care
5.2 By Application - UK In-Vitro Colorectal Cancer Screening Tests Revenue & Forecasts
  5.2.1 By Application - UK In-Vitro Colorectal Cancer Screening Tests Revenue, 2015-2020
  5.2.2 By Application - UK In-Vitro Colorectal Cancer Screening Tests Revenue, 2021-2026
  5.2.3 By Application - UK In-Vitro Colorectal Cancer Screening Tests Revenue Market Share, 2015-2026

6 PLAYERS PROFILES

6.1 Alere(Abbott)
  6.1.1 Alere(Abbott) Corporate Summary
  6.1.2 Alere(Abbott) Business Overview
  6.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.1.4 Alere(Abbott) Revenue in UK (2015-2020)
  6.1.5 Alere(Abbott) Key News
6.2 Beckman Coulter
  6.2.1 Beckman Coulter Corporate Summary
  6.2.2 Beckman Coulter Business Overview
  6.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.2.4 Beckman Coulter Revenue in UK (2015-2020)
  6.2.5 Beckman Coulter Key News
6.3 Siemens Healthcare
  6.3.1 Siemens Healthcare Corporate Summary
  6.3.2 Siemens Healthcare Business Overview
  6.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.3.4 Siemens Healthcare Revenue in UK (2015-2020)
  6.3.5 Siemens Healthcare Key News
6.4 Eiken Chemical
  6.4.1 Eiken Chemical Corporate Summary
  6.4.2 Eiken Chemical Business Overview
  6.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.4.4 Eiken Chemical Revenue in UK (2015-2020)
  6.4.5 Eiken Chemical Key News
6.5 Hitachi Chemical (Kyowa Medex)
  6.5.1 Hitachi Chemical (Kyowa Medex) Corporate Summary
  6.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
  6.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.5.4 Hitachi Chemical (Kyowa Medex) Revenue in UK (2015-2020)
  6.5.5 Hitachi Chemical (Kyowa Medex) Key News
6.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
  6.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Summary
  6.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
  6.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in UK (2015-2020)
  6.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Key News
6.7 Sysmex
  6.6.1 Sysmex Corporate Summary
  6.6.2 Sysmex Business Overview
  6.6.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.4.4 Sysmex Revenue in UK (2015-2020)
  6.7.5 Sysmex Key News
6.8 QIAGEN
  6.8.1 QIAGEN Corporate Summary
  6.8.2 QIAGEN Business Overview
  6.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.8.4 QIAGEN Revenue in UK (2015-2020)
  6.8.5 QIAGEN Key News
6.9 R-Biopharm
  6.9.1 R-Biopharm Corporate Summary
  6.9.2 R-Biopharm Business Overview
  6.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.9.4 R-Biopharm Revenue in UK (2015-2020)
  6.9.5 R-Biopharm Key News
6.10 Immunostics
  6.10.1 Immunostics Corporate Summary
  6.10.2 Immunostics Business Overview
  6.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Major Product Offerings
  6.10.4 Immunostics Revenue in UK (2015-2020)
  6.10.5 Immunostics Key News

7 KEY MARKET TRENDS & INFLUENCES 2021-2026

7.1 PESTLE Analysis for UK In-Vitro Colorectal Cancer Screening Tests Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of In-Vitro Colorectal Cancer Screening Tests in UK
Table 2. Top Players in UK, Ranking by Revenue (2019)
Table 3. UK In-Vitro Colorectal Cancer Screening Tests Revenue by Companies, (US$, Mn), 2015-2020
Table 4. UK In-Vitro Colorectal Cancer Screening Tests Revenue Share by Companies, 2015-2020
Table 5. UK In-Vitro Colorectal Cancer Screening Tests Sales by Companies, (K Units), 2015-2020
Table 6. UK In-Vitro Colorectal Cancer Screening Tests Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers In-Vitro Colorectal Cancer Screening Tests Price (2015-2020) (US$/Unit)
Table 8. UK Manufacturers In-Vitro Colorectal Cancer Screening Tests Product Type
Table 9. List of UK Tier 1 In-Vitro Colorectal Cancer Screening Tests Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of UK Tier 2 and Tier 3 In-Vitro Colorectal Cancer Screening Tests Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - In-Vitro Colorectal Cancer Screening Tests Revenue in UK (US$, Mn), 2015-2020
Table 12. By Type - In-Vitro Colorectal Cancer Screening Tests Revenue in UK (US$, Mn), 2021-2026
Table 13. By Type - In-Vitro Colorectal Cancer Screening Tests Sales in UK (K Units), 2015-2020
Table 14. By Type - In-Vitro Colorectal Cancer Screening Tests Sales in UK (K Units), 2021-2026
Table 15. By Application - In-Vitro Colorectal Cancer Screening Tests Revenue in UK, (US$, Mn), 2015-2020
Table 16. By Application - In-Vitro Colorectal Cancer Screening Tests Revenue in UK, (US$, Mn), 2021-2026
Table 17. By Application - In-Vitro Colorectal Cancer Screening Tests Sales in UK, (K Units), 2015-2020
Table 18. By Application - In-Vitro Colorectal Cancer Screening Tests Sales in UK, (K Units), 2021-2026
Table 19. Alere(Abbott) Corporate Summary
Table 20. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 21. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 22. Beckman Coulter Corporate Summary
Table 23. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 24. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 25. Siemens Healthcare Corporate Summary
Table 26. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 27. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 28. Eiken Chemical Corporate Summary
Table 29. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 30. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 31. Hitachi Chemical (Kyowa Medex) Corporate Summary
Table 32. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 33. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 34. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Summary
Table 35. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 36. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 37. Sysmex Corporate Summary
Table 38. Sysmex In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 39. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 40. QIAGEN Corporate Summary
Table 41. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 42. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 43. R-Biopharm Corporate Summary
Table 44. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 45. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)
Table 46. Immunostics Corporate Summary
Table 47. Immunostics In-Vitro Colorectal Cancer Screening Tests Product Offerings
Table 48. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (US$, Mn), (2015-2020)

LIST OF FIGURES

Figure 1. In-Vitro Colorectal Cancer Screening Tests Segment by Type
Figure 2. In-Vitro Colorectal Cancer Screening Tests Segment by Application
Figure 3. UK In-Vitro Colorectal Cancer Screening Tests Market Overview: 2020
Figure 4. Key Caveats
Figure 5. In-Vitro Colorectal Cancer Screening Tests Market Size in UK, (US$, Mn): 2020 VS 2026
Figure 6. UK In-Vitro Colorectal Cancer Screening Tests Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue in 2019
Figure 8. By Type - UK In-Vitro Colorectal Cancer Screening Tests Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - UK In-Vitro Colorectal Cancer Screening Tests Market Share, 2015-2026
Figure 10. By Application - In-Vitro Colorectal Cancer Screening Tests Revenue in UK (US$, Mn), 2020 & 2026
Figure 11. By Application - UK In-Vitro Colorectal Cancer Screening Tests Market Share, 2015-2026
Figure 12. PEST Analysis for UK In-Vitro Colorectal Cancer Screening Tests Market in 2020
Figure 13. In-Vitro Colorectal Cancer Screening Tests Market Opportunities & Trends in UK
Figure 14. In-Vitro Colorectal Cancer Screening Tests Market Drivers in UK


More Publications